Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Implant Sciences Corporation
Implant Sciences Announces Favorable Ruling in Evans Litigation
December 7th, 2008
Implant Sciences Corporation (NYSE Alternext US: IMX), a supplier of systems and sensors for the homeland security market and related industries, announced a favorable ruling on a key motion in its ongoing litigation with Evans Analytical Group, LLC. The Superior Court of the State of California, Santa Clara County, has denied a motion by Evans to attach substantial portions of the Company's assets prior to any final judgment on the merits of Evans' claims. As previously announced, Evans sued the Company in February 2008, seeking rescission of the sale of our Accurel Systems subsidiary. No trial date has yet been scheduled. Phillip C. Thomas, Implant...
Source: Pharma Investments, Ventures & Law Weekly (2008-12-07)
|
